Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00611533
First received: January 29, 2008
Last updated: August 24, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)